Verition Fund Management
FATE icon

Verition Fund Management’s Fate Therapeutics FATE Stock Holding History

Verition Fund Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,585
Closed -$88.4K – 3445
2024
Q4 		$88.4K Buy
+53,585
New +$135K ﹤0.01% 3089
2024
Q3 		– Sell
-36,675
Closed -$120K – 3290
2024
Q2 		$120K Buy
+36,675
New +$161K ﹤0.01% 2706
2023
Q4 		– Sell
-52,654
Closed -$112K – 2444
2023
Q3 		$112K Buy
+52,654
New +$174K ﹤0.01% 2106
2023
Q1 		– Sell
-12,744
Closed -$129K – 2276
2022
Q4 		$129K Buy
+12,744
New +$239K ﹤0.01% 1820
2021
Q4 		– Sell
-12,755
Closed -$756K – 2656
2021
Q3 		$756K Sell
12,755
-9,156
-42% -$718K 0.01% 1048
2021
Q2 		$1.9M Buy
+21,911
New +$1.77M 0.03% 551

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return